Top Page | English | 简体中文 | 繁體中文 | 한국어 | 日本語
Monday, 28 November 2016, 15:00 HKT/SGT

Source: Privity / AugmentCare
AugmentCare Appoints Privity as Advisor in its Early Stage Funding

DUBAI, UAE, Nov 28, 2016 - (ACN Newswire) - AugmentCare, an integrated digital healthcare platform focused on emerging markets, has announced the appointment of Privity FZ LLE, an independent venture-focused advisory firm, to assist in its first round of fundraising and the rolling-out of its public beta in Pakistan early next year (1Q2017).

AugmentCare ('AC') has built a platform which will connect patients, doctors, care facilities, payers and corporates, while providing the most comprehensive information for preventative, diagnostic and care facilitation. The AC solution set focuses on the patient journey across the continuum of care and addresses the challenges faced by all key stakeholders - patients, providers, doctors, caregivers, payers, corporates, pharmacists and diagnostics - with a particular understanding of Pakistan's healthcare system.

"What sets AugmentCare apart is our integrated approach and attention to a broad value chain, from discovery to care coordination, and remote monitoring to medicine fulfilment," said Ammar Afif, an AugmentCare co-founder. "This enables AC to empower all stakeholders in the care delivery process. It also differentiates AC from competitors that are solely focused on individual silos of this chain."

"At AugmentCare, we believe in the kind of innovation which transforms our lives into a virtual hyper connected reality, only making life so much sweeter. Being research and data driven, design-led and human-focused has helped us uncover the need for a comprehensive platform for the entire healthcare ecosystem. Doctors have shown an optimistic and keen interest in our private beta," said Ahmed Shuja, second co-founder of AugmentCare. "We have our first of set of doctors using the platform who will help us define the future of patient-first healthcare."

Hyder Mumtaz, the third AugmentCare co-founder, added, "Research has shown us that almost 50% of patients are self-medicating because of the low doctor patient ratios (1:1200+) and concentration in urban cities. These numbers are symptoms of the inefficiencies in the healthcare delivery process in Pakistan. We're positioned at the center of a fragmented healthcare system and want to enable all stakeholders to evolve towards preventive health behaviour and less out of pocket spend."

Sleem Hasan, Privity Founder & CEO, adds "I was most impressed by the backgrounds and professionalism of the AugmentCare co-founders, and feel fortunate that Privity was selected in partnering at this early stage. Privity grasps the potential of this platform in frontier and emerging markets. The AC machine learning focus will leverage data to build clinical support tools which demonstrate that prevention is truly cheaper than cure. We look forward to being part of this growth story in the years ahead."

About Privity

Privity FZ LLE was founded in 2004, an independent venture-focused advisory firm that seeks entrepreneurs with interesting and unique ideas and helps them develop and grow. Privity is agnostic to geography and industry vertical. It focuses on the quality of the entrepreneur and the compelling value proposition of the idea.

Privity draws upon its unique 4i methodology - ideas, intelligence, innovation, invention - to deliver insightful advisory and consulting services. This methodology is a result of Privity's diverse experience accumulated over the years as well as its highly specialized deep domain expertise which yields unique results for its clients. For more information, please visit

About AugmentCare

AugmentCare operates an integrated digital health platform which connects patients, providers, care facilities, payers and corporates, while providing the most comprehensive information for preventative, diagnostic and care facilitation. A patient-first approach enables AugmentCare to address key issues faced by care seekers in emerging economies.

AugmentCare Inc. is a Dubai-based Delaware incorporated company focusing on emerging economies, starting with Pakistan. Partners include Basehealth (USA) and Sehat (Pakistan). For more information please visit You can also follow us on Facebook at, Instagram at or Twitter at @AugmentCare.

Media Contact:

Hyder Mumtaz
+92 333 420 6455
+97 155 295 5179

Nov 28, 2016 15:00 HKT/SGT
Topic: Press release summary
Sectors: Daily Finance, Daily News, HealthCare, Venture Capital, Digital, Local
From the Asia Corporate News Network

Copyright © 2018 ACN Newswire. All rights reserved. A division of Asia Corporate News Network.

Latest Press Releases
Chief Executive encourages French companies to leverage opportunities in the Guangdong-HK-Macao Bay Area  
June 20, 2018 22:01 HKT/SGT
HKSAR Chief Executive encourages French companies to leverage opportunities in the Guangdong-HK-Macao Bay Area  
June 20, 2018 22:00 HKT/SGT
Stream Ideas Group Limited Announces FY2017/18 Annual Results  
June 20, 2018 21:45 HKT/SGT
HKBU scholars invent award-winning medical device for safe growth of neural stem cells using nanotechnology  
June 20, 2018 21:00 HKT/SGT
Hong Kong Q2 2018 Exports Index at 7-year High  
June 20, 2018 20:00 HKT/SGT
LivesOne World Singapore discusses Blockchain Innovation and Venture Capital  
June 20, 2018 16:20 HKT/SGT
DOCOMO Adds Amateur Sports Site to dmenu "Sports"  
June 20, 2018 14:36 HKT/SGT
Experian named by Forbes as one of the most innovative companies in the world for fifth consecutive year  
June 20, 2018 11:15 HKT/SGT
NEC Establishes "NEC X" in Silicon Valley  
June 20, 2018 11:12 HKT/SGT
Yahoo Mail for All: Introducing Our New Mobile Web Experience and Android Go App  
June 20, 2018 10:30 HKT/SGT
More Press release >>
 News Alerts
Copyright © 2018 ACN Newswire - Asia Corporate News Network
Home | About us | Services | Partners | Events | Login | Contact us | Privacy Policy | Terms of Use | RSS
US: +1 800 291 0906 | Beijing: +86 10 8405 3688 | Hong Kong: +852 2217 2912 | Singapore: +65 6304 8926 | Tokyo: +81 3 6721 7212

Connect With us: